Pharmaceutical

NHS England offers MSD belzutifan for von Hippel-Lindau disease

NHS England has announced the availability of MSD UK’s belzutifan, a take-at-home pill for patients with von Hippel-Lindau disease.

Sep 6, 2024 - 04:00
NHS England offers MSD belzutifan for von Hippel-Lindau disease
NHS England has announced the availability of MSD UK’s belzutifan, a take-at-home pill for patients with von Hippel-Lindau disease.
Read the original article

Tags:

Previous Article

IN8bio cuts staff and pipeline to focus on AML cell therapy

Next Article

UK bans xylazine and 21 other substances to fight drug abuse

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Merck is on the lookout for more opportunities within immunology

Merck is on the lookout for more opportunities within i...

Jan 29, 2024

NPX-267 by NextPoint Therapeutics for Prostate Cancer: Likelihood of Approval

NPX-267 by NextPoint Therapeutics for Prostate Cancer: ...

Jun 14, 2024

STAT+: MD Anderson tried — and failed — to resolve research credit dispute between two scientists, new documents show

STAT+: MD Anderson tried — and failed — to resolve rese...

Feb 27, 2024